John G. Hanly

20.5k citations

137 papers · 5.8k indexed · 2 hit papers · h-index 42

Impact in

Rheumatology top 0.1%
- Systemic Lupus Erythematosus Research
- Rheumatoid Arthritis Research and Therapies
Immunology top 1%
- Atherosclerosis and Cardiovascular Diseases
- T-cell and B-cell Immunology

Papers in

Rheumatology 107
- Systemic Lupus Erythematosus Research 87
- Rheumatoid Arthritis Research and Therapies 25
Immunology 48
- Atherosclerosis and Cardiovascular Diseases 28
- T-cell and B-cell Immunology 14

Co-authors: John D. Fisk Noreen M. Walsh Dafna D. Gladman Kara Thompson Stephanie A. Smith Paul R. Fortin Brian J. Eastwood Virgilio Sangalang
Journals: The Journal of Rheumatology (16 papers)Lupus (12 papers)Lara D. Veeken (9 papers)Annals of the Rheumatic Diseases (7 papers)Arthritis Care & Research (5 papers)
Partner nations: Canada United States United Kingdom

In The Last Decade

John G. Hanly

131 papers receiving 5.6k citations

Hit Papers

align trajectories log scale

Intermittent Etidronate Therapy to Prevent Corticosteroid-Induced Osteoporosis 1997 · 502 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

1997 New England Journal of Medicine
1997 Arthritis & Rheumatism

Peers

Countries citing papers authored by John G. Hanly

Since Specialization

Citations

This map shows the geographic impact of John G. Hanly's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John G. Hanly with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John G. Hanly more than expected).

Fields of papers citing papers by John G. Hanly

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John G. Hanly. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John G. Hanly. The network helps show where John G. Hanly may publish in the future.

Co-authors

The 25 scholars most cited alongside John G. Hanly, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with John G. Hanly Line = papers co-authored together John G. Hanly links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	An educational tool to improve PREeclamPsia knowledge and Aspirin adheRence in lupus prEgnancies: the PREPARE trial Lara D. Veeken ·Joo‐Young Lee, Arielle Mendel, Isabelle Malhamé, Megan R.W. Barber, Ann E. Clarke, Paul R. Fortin, John G. Hanly, Alexandra Legge, Christine Peschken, Carl A. Laskin, Zahi Touma, Murray B. Urowitz, Sasha Bernatsky, Évelyne Vinet	2025	0
2	From the Blood-Brain Barrier to Childhood Development: A Case of Acute-Onset Psychosis and Cognitive Impairment Attributed to Systemic Lupus Erythematosus in an Adolescent Female Harvard Review of Psychiatry ·Matthew C. Johnson, Aakash Sathappan, John G. Hanly, Gail Ross, Aaron J. Hauptman, William S. Stone, Kevin M. Simon	2022	1
3	Cognitive dysfunction in systemic lupus erythematosus: how do we advance our understanding? The Lancet Rheumatology ·Sudha Raghunath, Yifat Glikmann‐Johnston, John G. Hanly, Eric F. Morand, Julie C. Stout, Alberta Hoi	2022	7
4	Association of the Systemic Lupus International Collaborating Clinics Frailty Index and Damage Accrual in Longstanding Systemic Lupus Erythematosus Arthritis Care & Research ·Kaitlin Lima, Alexandra Legge, John G. Hanly, Jungwha Lee, Jing Song, Anh Chung, Rosalind Ramsey‐Goldman	2021	11
5	The neurology of lupus Journal of the Neurological Sciences ·John G. Hanly, Murat İnanç	2021	7
6	Management of inflammatory neurologic and psychiatric manifestations of systemic lupus erythematosus: A systematic review Seminars in Arthritis and Rheumatism ·Danaë A Papachristos, Shereen Oon, John G. Hanly, Mandana Nikpour	2020	24
7	Lipocalin-2 is a pathogenic determinant and biomarker of neuropsychiatric lupus Journal of Autoimmunity ·Elise V. Mike, Hadijat M. Makinde, Maria Gulinello, Kamala Vanarsa, Leal Herlitz, Gaurav Gadhvi, Deborah R. Winter, Chandra Mohan, John G. Hanly, Chi Chiu Mok, Carla M. Cuda, Chaim Putterman	2018	45
8	Managing premature atherosclerosis in patients with chronic inflammatory diseases Canadian Medical Association Journal ·Alexandra Legge, John G. Hanly	2018	5
9	Positron Emission Tomography/Computerized Tomography in Newly Diagnosed Patients with Giant Cell Arteritis Who Are Taking Glucocorticoids The Journal of Rheumatology ·Alison Clifford, E. Murphy, Steven Burrell, Mathew Bligh, Ryan F. MacDougall, J.G. Heathcote, Mathieu Castonguay, Min S. Lee, Kara Matheson, John G. Hanly	2017	25
10	Anti-DFS70/LEDGF Antibodies Are More Prevalent in Healthy Individuals Compared to Patients with Systemic Autoimmune Rheumatic Diseases The Journal of Rheumatology ·Michael Mähler, Todd A. Parker, Carol Peebles, Luís Eduardo Coelho Andrade, Andreas Swart, YVETTE CARBONE, David Ferguson, Danilo Villalta, Nicola Bizzaro, John G. Hanly, Marvin J. Fritzler	2012	115
11	Gout in the Elderly — A Population Health Study The Journal of Rheumatology ·John G. Hanly, Chris Skedgel, Ingrid Sketris, Charmaine Cooke, TINA LINEHAN, Kara Thompson, Sander Veldhuyzen van Zanten	2009	35
12	Physician resources and postgraduate training in canadian academic rheumatology centers: a 5-year prospective study. PubMed ·John G. Hanly	2004	15
13	IFN-γ-Inducible T Cell α Chemoattractant Is a Potent Stimulator of Normal Human Blood T Lymphocyte Transendothelial Migration: Differential Regulation by IFN-γ and TNF-α The Journal of Immunology ·Mohan Karkada, Ziqiang Ding, John G. Hanly, Thomas B. Issekutz	2002	60
14	Positive Effect of Etidronate Therapy Is Maintained After Drug Is Terminated in Patients Using Corticosteroids Journal of Clinical Densitometry ·Jacques P. Brown, Wojciech P. Olszynski, Anthony B. Hodsman, W. Bensen, Alan Tenenhouse, Tassos Anastassiades, Louis‐Georges Ste‐Marie, David L. Kendler, David A. Hanley, Robert G. Josse, John G. Hanly, Brian C. Lentle, A. Jovaisas, George Ioannidis, Greg F. Stephenson, I Barton, Simon Pack, Arkadi Chines, Reginald Dias, Jonathan D. Adachi	2001	8
15	A prospective analysis of cognitive function and anticardiolipin antibodies in systemic lupus erythematosus Arthritis & Rheumatism ·John G. Hanly, Connie Hong, Stephanie A. Smith, John D. Fisk	1999	163
16	Cognitive function in systemic lupus erythematosus: Results of a 5‐year prospective study Arthritis & Rheumatism ·John G. Hanly, Krista Cassell, John D. Fisk	1997	75
17	Cutaneous Sarcoidosis and Foreign Bodies American Journal of Dermatopathology ·Noreen M. Walsh, John G. Hanly, Robert Tremaine, Scott Murray	1993	60
18	COGNITIVE IMPAIRMENT AND AUTOANTLBODIES IN SYSTEMIC LUPUS ERYTHEMATOSUS Lara D. Veeken ·John G. Hanly, Noreen M. Walsh, John D. Fisk, Brian J. Eastwood, Connie Hong, Geoffrey K. Sherwood, John Verrier Jones, Elizabeth Jones, Keith B. Elkon	1993	74
19	The immunological consequences of gold therapy: a prospective study in patients with rheumatoid arthritis. PubMed Central ·Jaythoon Hassan, John G. Hanly, Barry Bresnihan, Conleth Feighery, Ciara Whelan	1986	12
20	Meconium ileus equivalent in older patients with cystic fibrosis. BMJ ·John G. Hanly, M X Fitzgerald	1983	22

About John G. Hanly

John G. Hanly is a scholar working on Rheumatology, Immunology, Neurology, Radiology, Nuclear Medicine and Imaging and Pathology and Forensic Medicine, having authored 137 papers that have together received 5.8k indexed citations. Recurring topics across this work include Systemic Lupus Erythematosus Research (87 papers), Atherosclerosis and Cardiovascular Diseases (28 papers), Monoclonal and Polyclonal Antibodies Research (26 papers), Rheumatoid Arthritis Research and Therapies (25 papers), Peripheral Neuropathies and Disorders (20 papers), T-cell and B-cell Immunology (14 papers), Systemic Sclerosis and Related Diseases (11 papers) and Autoimmune and Inflammatory Disorders Research (7 papers). The work is most often cited by research in Rheumatology (4.1k citations), Immunology (1.9k citations), Neurology (962 citations), Pathology and Forensic Medicine (1.0k citations) and Orthopedics and Sports Medicine (436 citations). John G. Hanly has collaborated with scholars based in Canada, United States and United Kingdom. Frequent co-authors include John D. Fisk, Noreen M. Walsh, Dafna D. Gladman, Kara Thompson, Stephanie A. Smith, Paul R. Fortin, Brian J. Eastwood, Virgilio Sangalang, Connie Hong and Marvin J. Fritzler. Their work appears in journals such as The Journal of Rheumatology, Lupus, Lara D. Veeken, Annals of the Rheumatic Diseases and Arthritis Care & Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact